On July 7, 2023 BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, reported that the Company will host an investor Research and Development Day in New York City and via webcast on July 18, 2023 (Press release, BeiGene, JUL 7, 2023, View Source [SID1234633108]). John V. Oyler, BeiGene’s Co-Founder, Chairman and CEO, along with the Company’s leadership team, will provide an update on BeiGene’s deep and broad global innovation pipeline and platforms, and share insights on the Company’s vision, differentiated capabilities, and value creation drivers.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live webcast of this event can be accessed from the investors section of BeiGene’s website at View Source , View Source or View Source Archived replays will be available for 90 days following the event.